Cross Country Healthcare (CCRN) Reports Mixed Q3 Results; Guides Q4
CCRN Hot Sheet
EPS Growth %: -300.0%Financial Fact:
Depreciation: 1.59M
Today's EPS Names:
MLAB, ZLC, GILT, More
Cross Country Healthcare, Inc. (NASDAQ: CCRN) reports Q3 EPS of $0.03, 1 cent better than the analyst estimate of $0.02. Revenue for the quarter was $129.6 million, which compares to the estimate of $132.37 million.
Sees Q4 EPS of $0.02-$0.04, versus the consensus of $0.03, on sales of $120-$123 million, versus the Street estimate of $137.08 million.
Sees Q4 EPS of $0.02-$0.04, versus the consensus of $0.03, on sales of $120-$123 million, versus the Street estimate of $137.08 million.
You May Also Be Interested In
- Xueda Education Group (XUE) Tops Q1 EPS by 6c; Guides Q2 Revs Above Views; Reaffirms FY12
- hhgregg, Inc. (HGG) Tops Q4 EPS by 2c; Issues FY13 Outlook
- Analog Devices, Inc. (ADI) Tops Q2 EPS by 2c; Guides In-line
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
